Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Sinovac Gains GMP Certification for New Production Facility | Contract Pharma

What are you searching for?

Sign in
Breaking News

Sinovac Gains GMP Certification for New Production Facility

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Sinovac Biotech Ltd. has received GMP certification from the China’s State Food and Drug Administration (SFDA) for its filling and packaging production facility. The certificate of compliance was issued following a site inspection and has a five-year term.

The GMP certification provides for an overall annual production capacity of 20 million doses, with the capability to produce as many as 40 million doses. This certification allows Sinovac to meet current and potential production increases for products including Healive, Bilive and Anflu. The production plant also has the capabilities to fill and package Panflu, the company’s pandemic flu vaccine.

Weidong Yin, chairman, president and chief executive officer, commented, “The receipt of the GMP certification and the operation of the state-of-the-art filling and packaging facility provide the foundation for the further development of Sinovac. We are well positioned to increase output to meet increasing market demand and ultimately achieve sales growth. More importantly, the expanded production capacity should enable Sinovac to supply greater amount of vaccines, which is in line with our mission to eliminate human diseases.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters